International Journal of Cancer Medicine

Journal Home Editor-in-Chief Editorial Board Articles in Press Current Issue Archive Author Guidelines Submit Manuscript

Home

The International Journal of Cancer Medicine, with a DOI prefix of 10.46619 and an Impact Factor of 4.2, is a peer-reviewed open access journal that covers all aspects of cancer research, particularly novel concepts and theories, new techniques, therapeutic agents, and alternative approaches for early detection and intervention of cancer.

The journal's objective is to advance the field of cancer or oncology by publishing articles focused on disease management, prevention, early diagnosis methods, specific classes of therapeutic agents, clinical trial results, emerging interventional techniques, supportive care, and rehabilitation /reconstruction. The journal's rigorous single-blinded peer-review process ensures the rapid publication of high-quality cancer research results.

Currently, all students and emeritus professors can submit and publish their manuscripts at a discounted rate. Additionally, the published articles are available to online readers free of charge.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Acceptance Rate
64%
Days to process
45
Days to publish
10
Total Articles
117

Recently Published Articles

Short Communication | Volume 6, Issue 3 | Open Access
Cancer Patients Admitted to the Emergency Department

Valéry Refeno, Rova Malala Fandresena Randrianarisoa, Hery Randrianirina, Ernestine Faly, Giannie Rasamimanana, Andriambelo Tovohery Rajaonera and Florine Rafaramino

Review Article | Special Issue | Open Access
Targeted and Immunotherapeutic Approaches in Breast Cancers

Rasit Dinc

Research Article | Special Issue | Open Access
Complement Components C3 and C7 as Potential Therapeutic and Prognostic Targets for Adrenocortical Carcinoma

Yongli Situ, Xiaoli Jiang, Ziqing Huang, Juying Zhang, Lingling Lu, Quanyan Liang, Li Deng, Qinying Xu and Zheng Shao

Clinical Research | Special Issue | Open Access
Regenerating Family Member 4 Expression was a Potential Marker for Carcinogenesis, Aggressiveness and Prognosis of Gastric Cancer

Cong-yu Zhang, Li Zhang, Hong-zhi Sun, Min-wen Ha, Zheng-guo Cui and Hua-chuan Zheng

Clinical Research | Special Issue | Open Access
Nivolumab Hepatocellular Carcinoma

Timothy Schieber, Matthew Arango, Kathryn Herr, Missy Sweeney, Eric Mclaughlin, Anne Noonan, and Daniel Kendzierski

Clinical Research | Special Issue | Open Access
Evaluation of Axillary Lymph Node Recurrence and Adverse Effects of Sentinel Lymph Node Biopsy with Single Technique Methylene Blue 1%: A Case Series in Indonesia

Dedy Hermansyah and Muhammad Al Anas

Clinical Research | Volume 6, Issue 3 | Open Access
Hematopoietic Stem Cell Transplantation Experience: A Retrospective Analysis from Largest Center of India’s Largest State

Sandeep kumar Jasuja, Mukesh Kumar, Aditi Mittal, Krutika Goyal, Sajna Choudhary, Ashish Dayma, Linu Hooda and Jaiprakash Yadav

Research Article | Special Issue | Open Access
Hypofractionated Preoperative Radiotherapy in Patients with Primary or Recurrent Osteosarcoma: A Retrospective Cohort Study

Serap Yucel, Zeynep Gural, Mustafa Sungur, Leyla Ozer, Harzem Özger and Fulya Ağaoğlu

Review Article | Special Issue | Open Access
Cancer Immunotherapy - Allergies and Degranulation

Michael J Dochniak

Case Report | Special Issue | Open Access
A Spontaneous Iliopsoas Hematoma: A Rare Problem

Soufiène Gabsi, Wael Ferjaoui, Achref Sarraj, Atef Mejri, Lasaad Gharbi and Malek Bakhtri

View More

Aims & Scope

The primary objective of the International Journal of Cancer Medicine is to enhance and disseminate knowledge and global health outcomes by promptly publishing top-quality research articles, reviews, and case reports conveying important practice messages to the scientific community. The journal welcomes all types of articles covering various areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and related fields, with the belief that the best research should be rapidly published and made widely accessible.

The International Journal of Cancer Medicine will accept submissions from all oncological specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals
  • Cancer Medicine and Metastasis